These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
590 related articles for article (PubMed ID: 20451859)
1. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. Segal L; Darvish-Zargar M; Dilenge ME; Ortenberg J; Polomeno RC J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859 [TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Thiagalingam S; Flaherty M; Billson F; North K Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338 [TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More. Kinori M; Armarnik S; Listernick R; Charrow J; Zeid JL Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094 [TBL] [Abstract][Full Text] [Related]
4. Optic Pathway Glioma and Cerebral Focal Abnormal Signal Intensity in Patients with Neurofibromatosis Type 1: Characteristics, Treatment Choices and Follow-up in 134 Affected Individuals and a Brief Review of the Literature. Friedrich RE; Nuding MA Anticancer Res; 2016 Aug; 36(8):4095-121. PubMed ID: 27466519 [TBL] [Abstract][Full Text] [Related]
5. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis]. Schröder S; Baumann-Schröder U; Hazim W; Haase W; Mautner VF Klin Monbl Augenheilkd; 1999 Dec; 215(6):349-54. PubMed ID: 10637799 [TBL] [Abstract][Full Text] [Related]
6. Neuroophthalmological management of optic pathway gliomas. Lee AG Neurosurg Focus; 2007; 23(5):E1. PubMed ID: 18004957 [TBL] [Abstract][Full Text] [Related]
7. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas. Avery RA; Bouffet E; Packer RJ; Reginald A Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1034-8. PubMed ID: 23329671 [TBL] [Abstract][Full Text] [Related]
8. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision. de Blank PMK; Fisher MJ; Liu GT; Gutmann DH; Listernick R; Ferner RE; Avery RA J Neuroophthalmol; 2017 Sep; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346 [TBL] [Abstract][Full Text] [Related]
9. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1. Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602 [TBL] [Abstract][Full Text] [Related]
10. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Balcer LJ; Liu GT; Heller G; Bilaniuk L; Volpe NJ; Galetta SL; Molloy PT; Phillips PC; Janss AJ; Vaughn S; Maguire MG Am J Ophthalmol; 2001 Apr; 131(4):442-5. PubMed ID: 11292406 [TBL] [Abstract][Full Text] [Related]
11. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. Chang BC; Mirabella G; Yagev R; Banh M; Mezer E; Parkin PC; Westall CA; Buncic JR Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226 [TBL] [Abstract][Full Text] [Related]
12. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1. Wan MJ; Ullrich NJ; Manley PE; Kieran MW; Goumnerova LC; Heidary G J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725 [TBL] [Abstract][Full Text] [Related]
13. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications. Shamji MF; Benoit BG Neurosurg Focus; 2007; 23(5):E3. PubMed ID: 18004965 [TBL] [Abstract][Full Text] [Related]
14. Orbital optic nerve gliomas in children with neurofibromatosis type 1. Zeid JL; Charrow J; Sandu M; Goldman S; Listernick R J AAPOS; 2006 Dec; 10(6):534-9. PubMed ID: 17189147 [TBL] [Abstract][Full Text] [Related]
15. Precocious and accelerated puberty in children with neurofibromatosis type 1: results from a close follow-up of a cohort of 45 patients. Pinheiro SL; Maciel J; Cavaco D; Figueiredo AA; Damásio IL; Donato S; Passos J; Simões-Pereira J Hormones (Athens); 2023 Mar; 22(1):79-85. PubMed ID: 36269545 [TBL] [Abstract][Full Text] [Related]
16. The role of surgery in optic pathway/hypothalamic gliomas in children. Goodden J; Pizer B; Pettorini B; Williams D; Blair J; Didi M; Thorp N; Mallucci C J Neurosurg Pediatr; 2014 Jan; 13(1):1-12. PubMed ID: 24138145 [TBL] [Abstract][Full Text] [Related]
17. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1. Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126 [TBL] [Abstract][Full Text] [Related]